NVCR

NovoCure Limited

NVCR · CIK 1645113 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$655M
20182025
Net Income−$136M
20182025
Operating CF−$49M
20182025
Free Cash Flow−$76M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.7B$0.6B$0.5B$0.1B$0.1B$0.1B$0.1B$0.1B
Cost of Revenue$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Gross Profit$0.5B$0.5B$0.4B$0.1B$0.1B$0.1B$0.1B$0.0B
R&D Expense$0.2B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B
SG&A Expense————————
Operating Income$-0.2B$-0.2B$-0.2B$-0.0B$-0.0B$0.0B$0.0B$-0.0B
Net Income$-0.1B$-0.2B$-0.2B$-0.0B$-0.0B$0.0B$0.0B$-0.0B
EPS (Basic)$-1.22$-1.56$-1.95$-0.36$-0.25$0.05$0.04—
EPS (Diluted)$-1.22$-1.56$-1.95$-0.36$-0.25$0.04$0.04—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.8B$1.2B$1.1B$1.2B$1.1B$1.1B$0.5B$0.3B
Current Assets$0.6B$1.1B$1.0B$1.1B$1.1B$1.0B$0.4B$0.3B
Cash & Equivalents$0.1B$0.2B$0.2B$0.1B$0.2B$0.2B$0.2B$0.1B
Total Liabilities$0.5B$0.9B$0.8B$0.8B$0.7B$0.6B$0.3B$0.2B
Current Liabilities$0.2B$0.8B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$0.3B$0.4B$0.4B$0.4B$0.4B$0.5B$0.2B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.0B$-0.0B$-0.1B$0.0B$0.1B$0.1B$0.0B$-0.0B
Investing Cash Flow$0.4B$-0.1B$0.2B$-0.1B$-0.1B$-0.5B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.5B$0.1B$0.0B$0.0B$0.0B$0.4B$0.1B$0.1B
← Companies